Rebrand and site redesign for a state-of-the-art pharmaceutical company.
A pharmaceutical company based in Norway, Algeta were in the process of developing a new drug for cancer patients. To reflect their brand clearly and cohesively to potential new investors, August were tasked in updating their existing print and digital presence. I led the digital design while collaborating with print designers on our team to create a cohesive rebrand across all mediums.
Algeta received a lot of additional interest after we went live with the project and around 6 to 8 months later they were fully acquired by Bayer AG for $2.9 billion.